SCPH missed EPS expectations by 21.71%
May 14, 2025, 10:34 PM
0.00%
What does SCPH do
scPharmaceuticals, based in Burlington, Massachusetts, focuses on developing subcutaneous delivery products like FUROSCIX for outpatient care. The company, founded in 2017 and employing 135 staff, aims to enhance patient care and reduce healthcare costs.
scPharmaceuticals (SCPH) reported a negative EPS surprise in its most recent quarterly earnings. For the most recent quarter, scPharmaceuticals's actual EPS was -$0.37, missing the estimate of -$0.30 per share, resulting in a -21.71% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.